New drug for schizophrenics has experts excited
The drug, called Cobenfy and developed by US pharma giant Bristol Myers Squibb, works differently from existing treatments, targeting the so-called cholinergic receptors, not the dopamine receptors.
PREMIUM Health
Two clinical trials confirmed its effectiveness, showing it can significantly reduce patients' symptoms. File photo
By NewVision Reporter
Journalists @NewVision
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades.
The drug, called Cobenfy and developed by US pharma giant